AAM, really an outstanding post. Most of the major players in this group have some sort of connection going back many years, and are African-Americans.They have all stated they want to create a global company and provide high quality, high paying jobs for the black youths in impoverished communities through medicinal marijuana. Very commendable IMO.But they have to be a successful company to do that. The Merck connection is interesting. Now big pharma is about to lose big bucks because the opioid epidemic is about to be shut down. So they will be forced to turn to the medicinal marijuana market just to keep pace. They have drug their feet in this market-too busy racking in millions off of addictive prescription drugs. Without joining with smaller companies to provide for their needs they will lose millions. Enter Merck. The CEO of Merck just happens to be an African American. Now what about a buyout-seems logical but is Merck prepared to go this route without professionals like Dalton, Goldman, Crockett, etc. Dont think so. Of course they could put them all on their BOD, but they need their expertise on the ground doing the hard work. My mentor Kgem told me he has been through 2 buyouts and both took 6-7 months to get his money. Now waiting 6-7 months on a million dollars is not what I would call a miserable thing, but then we are out if Merck buys these companies. Someone suggested maybe .25-.30 cents-that would make most that million, but a year from now if Merck is just a partner through some sort of JV, we will surpass that and much more and possibly still have some shares left over. I guess that is a good problem to ponder. You DD guys are amazing-not very helpful on my part but I did not grow up with computers and iphones so I have to just peck along. I have had the privilege of chatting with D. Dalton on occasions and can promise he is a trustworthy CEO. And good things ahead, regardless of what route we take. God Bless. JB
News 
Market Data 
Discover 
AI
